Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Non Operating Income: 2020-2025

Historic Non Operating Income for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Sep 2025 value amounting to -$71,000.

  • Maravai Lifesciences Holdings' Non Operating Income fell 198.61% to -$71,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.1 million, marking a year-over-year decrease of 74.13%. This contributed to the annual value of -$2.3 million for FY2024, which is 75.09% down from last year.
  • Maravai Lifesciences Holdings' Non Operating Income amounted to -$71,000 in Q3 2025, which was up 98.25% from -$4.1 million recorded in Q2 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Non Operating Income peaked at $914,000 during Q4 2022, and registered a low of -$4.1 million during Q2 2025.
  • For the 3-year period, Maravai Lifesciences Holdings' Non Operating Income averaged around -$707,909, with its median value being $43,000 (2024).
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Non Operating Income skyrocketed by 3,450.00% in 2021 and then crashed by 42,400.00% in 2022.
  • Quarterly analysis of 5 years shows Maravai Lifesciences Holdings' Non Operating Income stood at $201,000 in 2021, then skyrocketed by 354.73% to $914,000 in 2022, then plummeted by 94.64% to $49,000 in 2023, then dropped by 12.24% to $43,000 in 2024, then tumbled by 198.61% to -$71,000 in 2025.
  • Its last three reported values are -$71,000 in Q3 2025, -$4.1 million for Q2 2025, and $24,000 during Q1 2025.